Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06273319Not yet recruiting
Randomised, open-label trial of oxygen (2 arms), sponsored by Inonu University. Primary endpoint: Determination of the amount of oxygen to prevent the peripheral oxygen saturation of the patients from falling below 95% up to 24 weeks. Planned start Mar 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06273319.